Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia

2002 ◽  
Vol 144 (4) ◽  
pp. G1-G8 ◽  
Author(s):  
Vojtech Melenovsky ◽  
Jan Malik ◽  
Dan Wichterle ◽  
Jan Simek ◽  
Alexandra Pisarikova ◽  
...  
2005 ◽  
Vol 51 (7) ◽  
pp. 1192-1200 ◽  
Author(s):  
Simona Stan ◽  
Emile Levy ◽  
Edgard E Delvin ◽  
James A Hanley ◽  
Benoît Lamarche ◽  
...  

Abstract Background: Smaller, denser LDL particles are associated with an increased risk for cardiovascular diseases (CVD). In youths, data on the distribution of LDL particle size and on its association with other CVD risk factors are limited. Methods: We determined LDL peak particle size by nondenaturing 2%–16% gradient gel electrophoresis in a representative sample of 2249 youths 9, 13, and 16 years of age who participated in a school-based survey conducted in 1999 in the province of Quebec, Canada. Standardized clinical measurements and fasting plasma lipid, glucose, and insulin concentrations were available. Results: The LDL peak particle size distribution was gaussian. The 5th, 50th (median), and 95th percentiles by age and sex were 255.5–258.6, 262.1–263.2, and 268.1–269.5 Å, respectively. The prevalence of the small, dense LDL phenotype (LDL peak particle size ≤255 Å) was 10% in participants with insulin resistance syndrome (IRS), in contrast to 1% in those without IRS. In a multiple regression analysis, the association of LDL size with other CVD risk factors [apolipoprotein B, HDL-cholesterol (HDL-C), triglyceride (TG), and insulin concentrations, and body mass index] was strongest with TG and HDL-C concentrations: a 1 SD increase in loge-transformed TG concentration was associated with a 1.2 Å reduction in LDL size, and a 1 SD increase in HDL-C was associated with a 1.1 Å increase in LDL size. Conclusions: Although the small, dense LDL phenotype is less prevalent in youths than adults, its prevalence is clearly increased in childhood IRS. Metabolic correlates of LDL size are similar in youths and adults.


2004 ◽  
Vol 66 (3) ◽  
pp. 229-236 ◽  
Author(s):  
Jun Matsui ◽  
Naoki Tamasawa ◽  
Jutaro Tanabe ◽  
Nobuhiko Kasai ◽  
Hiroshi Murakami ◽  
...  

2000 ◽  
Vol 148 (1) ◽  
pp. 141-149 ◽  
Author(s):  
Yechiel Friedlander ◽  
Miriam Kidron ◽  
Muriel Caslake ◽  
Tracey Lamb ◽  
Michael McConnell ◽  
...  

1995 ◽  
Vol 240 (1) ◽  
pp. 63-73 ◽  
Author(s):  
G.A. Tallis ◽  
M.D.S. Shephard ◽  
S. Sobecki ◽  
M.J. Whiting

Cardiology ◽  
2007 ◽  
Vol 108 (4) ◽  
pp. 282-289 ◽  
Author(s):  
Jae-Youn Moon ◽  
Hyuck Moon Kwon ◽  
Sung Woo Kwon ◽  
Se-Jung Yoon ◽  
Jung-Sun Kim ◽  
...  

Circulation ◽  
2012 ◽  
Vol 125 (suppl_10) ◽  
Author(s):  
Emilie Pelletier Beaumont ◽  
Jean Bergeron ◽  
Natalie Alméras ◽  
Angelo Tremblay ◽  
Paul Porier ◽  
...  

Numerous studies have demonstrated improvements in lipid and lipoprotein levels with endurance exercise training and weight loss. However, less is known about the contribution of the enzyme cholesteryl ester transfer protein (CETP) to the response of lipoprotein levels to a physical activity/healthy eating lifestyle modification program. Objective: To examine the effect of a 1-year lifestyle modification program inducing loss of visceral adipose tissue on plasma CETP mass in abdominally obese dyslipidemic men. Methods: Plasma CETP mass concentration was measured by ELISA at baseline and after a 1-year lifestyle modification program in 116 abdominally obese men aged 30 to 65 years without diabetes. Visceral adiposity was assessed by computed tomography and a complete fasting plasma lipoprotein-lipid profile was also obtained at baseline and after the intervention. Results: After 1 year, no significant changes were observed in CETP mass (1.91±0.45 vs.1.93±0.49 mg/l, ns). However, both HDL (81.7±2.1 vs. 83.8±3.1 Å, p<0.0001) and LDL (252.1±3.9 vs. 253.6±3.7 Å, p<0.0001) particle sizes assessed by gradient gel electrophoresis were increased. Whereas no significant correlation between change in HDL size and CETP mass was observed, change in LDL size was significantly correlated with change in CETP mass (r=−0.30, p=0.001). We also divided men into two groups: men who showed no change or an increase in their CETP mass (ΔCETP≥0) and men who decreased their CETP mass (ΔCETP<0). Men who reduced their CETP mass after one year showed a greater increase in LDL size (Δ 2.37±3.18 vs.0.32±3.04 Å, p=0.0006) and a greater decrease in triglyceride levels (Δ-0.70±0.86 vs. −0.34±0.80 mmol/l, p=0.03) than men who showed no change or an increase in CETP mass. A Multivariate analysis revealed that 19% of the variance in the response of LDL size could be attributed to changes in triglyceride levels (15%) and in CETP mass (4%) (p=0.02). Conclusion: Whereas no significant change in CETP mass was observed, our results showed that individual variation in the response of CETP mass contributed to the response of LDL particle size to a 1-yr lifestyle modification program in viscerally obese dyslipidemic men.


Sign in / Sign up

Export Citation Format

Share Document